ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.290
+0.060 (4.88%)
At close: Apr 23, 2025, 4:00 PM
1.340
+0.050 (3.88%)
Pre-market: Apr 24, 2025, 8:19 AM EDT
ADC Therapeutics Employees
As of December 31, 2024, ADC Therapeutics had 265 total employees, including 263 full-time and 2 part-time employees. The number of employees decreased by 9 or -3.28% compared to the previous year.
Employees
265
Change (1Y)
-9
Growth (1Y)
-3.28%
Revenue / Employee
$267,309
Profits / Employee
-$595,645
Market Cap
127.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265 | -9 | -3.28% |
| Dec 31, 2023 | 274 | -43 | -13.56% |
| Dec 31, 2022 | 317 | 5 | 1.60% |
| Dec 31, 2021 | 312 | 104 | 50.00% |
| Dec 31, 2020 | 208 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ADCT News
- 22 days ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 23 days ago - ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 27 days ago - ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update - PRNewsWire
- 4 weeks ago - ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 - PRNewsWire
- 4 weeks ago - ADC Therapeutics: Promise Remains, But Fortunes Rest On Success Of Single Trial In 2025 - Seeking Alpha
- 5 weeks ago - ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025 - PRNewsWire
- 3 months ago - ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - PRNewsWire